REGENXBIO Inc. (RGNX) Dividend History

REGENXBIO Inc. (RGNX) is a biotechnology company specializing in the development and commercialization of gene therapy treatments. Founded in 2013, it focuses on leveraging its proprietary NAV Technology platform to create novel therapeutic options for a range of genetic, neurovascular, and retinal diseases. The company's goal is to advance gene therapy science and deliver transformative treatments to patients.

9804 Medical Center Drive, Rockville, MD, 20850
Phone: 240-552-8181
Website: https://www.regenxbio.com

Dividend History

REGENXBIO Inc. currently does not pay dividends

Company News

Page data last updated 07/23/2025 16:15:24 UTC